Asian Spectator

Times Advertising

FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review

  • Written by PR Newswire Asia - Asian Spectator
FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review

MELBOURNE, Australia, Feb. 26, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United States (U.S.) Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for its breakthrough investigational kidney cancer PET[1] imaging agent TLX250-CDx...

Magazine

Algorithms don’t care: how AI worsens the double burden for Indonesia’s female gig workers

Artificial intelligence is often celebrated as the future of work. It is efficient, innovative and neutral. Yet, for many women in Indonesia’s gig economy, AI feels like a source of mounting pre...

Tes jenis kelamin atlet untuk melarang trasgender justru berisiko menggagalkan perempuan interseks ikut olimpiade

Tes jenis kelamin di olahraga elite memiliki sejarah panjang yang tidak konsisten.anton5146/iStock via Getty Images PlusPada 26 Maret 2026, Komite Olimpiade Internasional (IOC) mengumumkan kebijakan b...

Loker di Indonesia: Perusahaan khawatir Gen Z lembek, tapi enggan rekrut senior yang tahan banting

● Kondisi ketenagakerjaan nasional berada dalam tahap yang memprihatinkan sejak lama.● Para pemberi kerja enggan merekrut Gen Z, tapi juga emoh merekrut pekerja dari generasi senior.●...